<DOC>
	<DOCNO>NCT03038152</DOCNO>
	<brief_summary>The goal clinical research study learn safety effectiveness marker call Magseed use help participant 's doctor locate lymph node contain cancer participant 's arm surgery . The Magseed marker small metallic marker ( small grain rice ) place near lymph node participant 's radiologist .</brief_summary>
	<brief_title>Study Use Magseed Sentimag Localize Axillary Lymph Nodes</brief_title>
	<detailed_description>Study Visits : If participant agrees take part study , participant come clinic 3 study visit : Marker Placement Procedure : If participant become pregnant , blood ( 1 teaspoon ) urine collect pregnancy test participant 's marker placement procedure . To take part study , participant must pregnant . After numb skin local anesthetic , Magseed marker inject near near lymph node participant 's arm . The person inject Magseed marker may use ultrasound mammogram position needle properly . Participant leave dress arm . Targeted Lymph Node Removal : After participant give general anesthetic make participant sleep , participant 's doctor perform lymph node removal procedure . As part procedure , doctor use handheld device scan participant 's arm locate marker . Participant sign separate consent form explain surgical procedure risk . Following removal lymph node ( ) marker , study test complete participant 's doctor continue standard care operate room . Post-Operative Visit : Within 2-6 week participant 's surgery , participant return routine follow-up visit . During visit , participant ask question side effect injury since participant 's surgery drug participant may take . It take 10 minute answer question . Length Study Participation : Participation study participant complete visit surgery . Participant 's total time study 3-6 week . This investigational study . The Magseed marker FDA approve locate breast tumor . It investigational use marker locate lymph node contain cancer doctor remove . Up 50 participant take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Breast Diseases</mesh_term>
	<criteria>1 . Age 18 year time consent 2 . Histologically confirm cT04 , N1 breast cancer 3 . Axillary lymph node metastasis pathologic confirmation needle biopsy 4 . Clip place sampled axillary lymph node time biopsy 5 . Received neoadjuvant chemotherapy prior surgical resection 6 . Scheduled targeted axillary dissection ( defined selective localization removal clip node SLND ) 7 . ECOG performance status 02 1 . Distant metastases 2 . Inflammatory breast cancer 3 . Prior surgical axillary procedure include SLND axillary node excision 4 . Prior history breast cancer ipsilateral breast 5 . History lymphoma 6 . The subject pregnant 7 . Previous radiation breast axilla 8 . Pacemaker implantable device chest wall</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Disorder breast</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Lymph node metastasis</keyword>
	<keyword>Magseed marker</keyword>
	<keyword>Lymph node removal</keyword>
</DOC>